SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458506075651v1
13/7/915    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by de Sèze, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Sèze, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines

Marianne de Sèze

Unité d'Evaluation et de Traitement du handicap Urinaire, Service de Médecine Physique et de réadaptation, CHU Pellegrin, Equipe de recherche Handicap et Système nerveux, Université Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France, marianne.de-seze{at}chu-bordeaux.fr

Alain Ruffion

Service d'Urologie, Hôpital Henry Gabrielle, CHU Lyon, 69565 Saint Genis Laval Cedex, France

Pierre Denys

Service de Rééducation neurologique, Hôpital Raymond Poincaré, APHP, 92380 Garches Cedex, France

Pierre-Alain Joseph

Unité d'Evaluation et de Traitement du handicap Urinaire, Service de Médecine Physique et de réadaptation, CHU Pellegrin, Equipe de recherche Handicap et Système nerveux, Université Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France

Brigitte Perrouin-Verbe

Service de Médecine Physique et de Réadaptation, Hôpital Saint Jacques, CHU de Nantes, 44093 Nantes Cedex, France

International Francophone Neuro-Urological expert study group (GENULF)

Vesicourethral dysfunction is very frequent in multiple sclerosis (MS) and has functional consequences for patients' quality of life and also an organic impact following complications of the neurogenic bladder on the upper urinary tract. While the functional impact and its management are well documented in the literature, the organic impact remains underestimated and there are no consensual practical guidelines for the screening and prevention of MS neurogenic bladder complications. The aim of this review of the literature, focused on identifying the risk factors of urinary tract complications in MS, is to put forward well informed considerations to help in the definition of practical guidelines for the follow-up of the neurogenic bladder in MS in order to improve its prevention and patient management. Four main risk factors have been identified for upper urinary tract damage: the duration of MS, the presence of an indwelling catheter, high-amplitude neurogenic detrusor contractions and permanent high detrusor pressure. Detrusor-sphincter dyssynergia, age over 50 and male sex may form three additional risk factors. Recommendations for long-term urological follow-up, taking into account these specific risks are constructed according to the procedures recommended by the French Health Authorities. Multiple Sclerosis 2007; 13: 915-928. http://msj.sagepub.com

Key Words: multiple sclerosis • neurogenic bladder • overactive bladder • upper urinary tract abnormalities • ureterohydronephrosis • urinary tract infection

This version was published on August 1, 2007

Multiple Sclerosis, Vol. 13, No. 7, 915-928 (2007)
DOI: 10.1177/1352458506075651


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
C J Fowler, J N Panicker, M Drake, C Harris, S C W Harrison, M Kirby, M Lucas, N Macleod, J Mangnall, A North, et al.
A UK consensus on the management of the bladder in multiple sclerosis
Postgrad. Med. J., October 1, 2009; 85(1008): 552 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C J Fowler, J N Panicker, M Drake, C Harris, S C W Harrison, M Kirby, M Lucas, N Macleod, J Mangnall, A North, et al.
A UK consensus on the management of the bladder in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 470 - 477.
[Abstract] [Full Text] [PDF]



Advertisement